scispace - formally typeset
R

Robert P. Finger

Researcher at University Hospital Bonn

Publications -  144
Citations -  5096

Robert P. Finger is an academic researcher from University Hospital Bonn. The author has contributed to research in topics: Visual acuity & Pseudoxanthoma elasticum. The author has an hindex of 38, co-authored 144 publications receiving 4206 citations. Previous affiliations of Robert P. Finger include University of Cologne & University of Bonn.

Papers
More filters
Journal ArticleDOI

High-Resolution Spectral Domain-OCT Imaging in Geographic Atrophy Associated with Age-Related Macular Degeneration

TL;DR: SD-OCT imaging in eyes with GA revealed a wide spectrum of morphologic alterations, both in the surrounding retinal tissue and in the atrophic area, which may reflect different disease stages or, alternatively, heterogeneity on a cellular and molecular level.
Journal ArticleDOI

Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches.

TL;DR: Different therapeutic strategies to treat retinal manifestations are discussed, including thermal laser coagulation, photodynamic therapy, and intravitreal injections of drugs inhibiting vascular endothelial growth factor.
Journal ArticleDOI

Cataract Surgical Rate and Socioeconomics: A Global Study.

TL;DR: Cataract surgical rate and economic indicators are closely associated, indicating the strong influence of resource availability on healthcare delivery and it is important to be innovative in delivery of low-cost services and invest strategically in capacity development to meet cataract surgical need in low-resource settings.
Journal ArticleDOI

The economic burden of visual impairment and blindness: a systematic review.

TL;DR: VI&B cause a considerable economic burden for affected persons, their caregivers and society at large, which increases with the degree of visual impairment, and this review provides insight into the distribution of costs and the economic impact.
Journal ArticleDOI

Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany.

TL;DR: Evaluation of effectiveness, tolerability and safety of repeated intravitreal injections of 0.5 mg ranibizumab for the treatment of neovascular age‐related macular degeneration in routine medical practice in Germany.